Decoding Parkinson’s disease with AI and the cloud
PharmaTimes Magazine
PharmaTimes is the UK’s leading pharmaceutical magazine, tracking the trends and issues that affect the industry here in the UK, in Europe and across the world. We deliver independent, authoritative and trustworthy content through impartial, balanced and informed opinion and analysis.
PharmaTimes print and digital magazine has a distributed circulation of 19,000, reaching right across the industry into every company and every function, bridging the gap between Pharma and the NHS.
Click to subscribe to PharmaTimes in paper or print, or to sign up for our industry-leading daily and weekly news elerts.
You can read the latest issue as well as our extensive archive below or get in touch with the editorial or sales team.
Magazine highlights
You and AI
Why appreciating representative trial participation matters
Time to shine
Coming out of the dark – a new decade for the NHS?
Epic scales
Pharma’s $100bn+ opportunity to redefine obesity treatment
July/August 2025
In this bold edition we talk about weight loss drugs – are they healthcare products, an NHS saviour or a complex cosmetic project? We also follow the astonishing and seemingly unstoppable acceleration of AI and the instant impact it is having on industry marketing, the use of data and humankind itself. Features on future innovation, decoding Parkinson’s disease, pharmacovigilance, the link between animal and public health, a review of our International Clinical Researcher of the Year Awards and what decisions must be made about the NHS, complete a tubthumping edition of pharma’s most intrepid periodical.
Script headache
Exploring the disparities in drug availability and patient access
Data with destiny
The big next step for European Medicines Agency’s IDMP
Trials of the century
The idea of putting patients first must become a stark reality
